Phreesia, Inc. (NYSE: PHR) reported fiscal fourth‑quarter and full‑year 2026 results on March 30, 2026. Revenue rose 16% year‑over‑year to $127.1 million, slightly beating the consensus estimate of $126.86 million. Earnings per share were $0.02, a miss versus the $0.06–$0.07 estimate. GAAP net income turned positive at $2.3 million, and adjusted EBITDA for the year reached $101.5 million. Free cash flow was $28.5 million for the quarter and $54.4 million for the year, underscoring the company’s growing cash‑generating capacity.
The EPS miss reflects a combination of weaker demand from pharmaceutical clients and the broader market softness that has reduced spending on marketing and technology solutions. While revenue edged ahead of expectations, the lower margin contribution from the Network Solutions segment, which has faced headwinds from regulatory changes and reduced client visibility, pulled earnings down. The company’s cost‑control program and operational leverage helped keep losses limited, but the shortfall in earnings per share indicates that the company’s profitability is still sensitive to the cyclical nature of its core market.
Revenue beat the consensus estimate by roughly $0.24 million, driven largely by the Payment Processing segment, which has benefited from the recent AccessOne acquisition and increased adoption of its payment platform. The Network Solutions segment, however, experienced modest growth, offsetting some of the upside from payments. The overall 14% year‑over‑year increase in full‑year revenue reflects a balanced mix of growth in both segments, but the narrower margin in Network Solutions tempers the upside.
Management cut its fiscal 2027 revenue guidance to $510–$520 million from the prior $545–$559 million, citing reduced visibility into pharmaceutical client spending and weaker commitments for the second half of the year. The company maintained its adjusted EBITDA outlook, signaling confidence in its operating leverage and the ability to drive further efficiency gains. The guidance reduction signals caution about near‑term demand while affirming the company’s focus on profitability.
Investors reacted negatively to the earnings miss and the revenue outlook cut, with analysts revising their expectations for the company’s near‑term performance. The market’s response highlights the importance of earnings accuracy and guidance clarity for a company that has recently turned profitable.
"We achieved several critical financial milestones ahead of our internal targets, including achieving positive GAAP net income ($2.3 million) and crossing $100 million of Adjusted EBITDA1 and $50 million of free cash flow2 ($78.8 million net cash from operating activities) for fiscal year 2026." – Chaim Indig, CEO and Co‑Founder
"2026 was an important year for Phreesia's evolution as a profitable company. For the first year ever, we achieved positive net income and earnings per share." – Balaji Gandhi, CFO
"We are lowering our revenue outlook for fiscal year 2027. We now expect revenue to be in the range of $510 million to $520 million compared to our prior range of $545 million to $559 million." – Balaji Gandhi, CFO
"It is worth noting that we are holding our adjusted EBITDA outlook even as we reduce our revenue range, a reflection of the operating leverage we have built and our ability to respond quickly with further efficiency gains." – Balaji Gandhi, CFO
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.